More
    Guided Solutions - Connecting Talent With Innovation/div>

    Piomic Medical raises CHF 7.5M oversubscribed financing round

    Following strong market feedback and results of its first-in-human clinical trial, Piomic has recently closed an oversubscribed Series A round of CHFM 7.5. The...

    PayGround Raises $5.5M in Latest Funding Round

    FCA Venture Partners and Lewis & Clark Ventures lead financing to fuel commercial growth  PayGround, a healthcare fintech payments platform, announced the completion of a $5.5M funding...

    Caraway raises $10.5M seed to offer virtual care to college women

    The startup plans to launch its team-based mental, physical and reproductive healthcare in the fall. Caraway, a virtual care startup focused on providing mental, physical...

    Heart attack prediction startup Cleerly scores $192M and more digital health fundings

    Also: Primary care tech company Elation Health raised $50 million, and patient intake chatbot Health Note closed a $17 million Series A. Cardiovascular disease-focused Cleerly...

    Direct primary care provider Everside Health scores $164M

    Everside recently scrapped plans for an IPO due to market conditions. Direct primary care provider Everside Health scooped up $164 million in growth equity funding.  The...

    Kry completes fundraising of $160m to support better healthcare for millions more patients

    Kry has secured over $160m in funding as it continues to boost access to healthcare for millions of patients. The fundraising round was from a combination of...

    Connected healthcare platform Eka Care scores $15M in Series A funding

    Eka Care, a healthcare technology startup in India, has snapped up $15 million in a Series A funding round led by Hummingbird Ventures.  The investing...

    Stimdia Medical raises $16M for neurostim to get people off ventilators

    Stimdia Medical announced recently that it completed the initial closing of a $16 million tranche of its Series B financing round. Solas Bioventures led the financing...

    Delfi Diagnostics raises $225m

    Delfi will use the proceeds to develop blood tests for early cancer detection as well as treatment monitoring. Delfi Diagnostics has raised $225m in a Series B...

    Latest articles